| scholarly article | Q13442814 |
| P2093 | author name string | E Gotuzzo | |
| M Guzman | |||
| D J Kopecko | |||
| C Fernandez-Prada | |||
| M M Venkatesan | |||
| J M Buysse | |||
| R A Oberhelman | |||
| A Yi | |||
| E Salazar-Lindo | |||
| R León-Barúa | |||
| P2860 | cites work | Characterization of invasion plasmid antigen genes (ipaBCD) from Shigella flexneri | Q33682684 |
| Immunobead enzyme-linked immunosorbent assay for quantitating immunoglobulin A in human secretions and serum | Q33905434 | ||
| Molecular cloning of invasion plasmid antigen (ipa) genes from Shigella flexneri: analysis of ipa gene products and genetic mapping | Q36238161 | ||
| Alterations in the pathogenicity of Escherichia coli K-12 after transfer of plasmid and chromosomal genes from Shigella flexneri | Q36347107 | ||
| Shigella flexneri invasion plasmid antigens B and C: epitope location and characterization with monoclonal antibodies | Q37000878 | ||
| Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp | Q37010733 | ||
| Identification and antigenic characterization of virulence-associated, plasmid-coded proteins of Shigella spp. and enteroinvasive Escherichia coli | Q37031232 | ||
| Enteropathogenic agents in children with diarrhoea in rural Zaire | Q38966386 | ||
| Enteropathogens associated with pediatric diarrhea in Mexico City | Q40079457 | ||
| Prospective study of enteropathogens in children with diarrhea in Houston and Mexico | Q40172037 | ||
| Efficacy of trimethoprim-sulfamethoxazole in treatment of acute diarrhea in a Mexican pediatric population | Q40796847 | ||
| Comparison of serum and fecal antibody responses of patients with naturally acquired Shigella sonnei infection | Q44024371 | ||
| Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats | Q52221980 | ||
| Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population | Q68134308 | ||
| Local and systemic antibody responses to Shigella infection in rhesus monkeys | Q68944588 | ||
| Immunity in Shigellosis. II. Protection Induced by Oral Live Vaccine or Primary Infection | Q69156182 | ||
| Serological response to plasmid-encoded antigens in children and adults with shigellosis | Q70247092 | ||
| Shigellosis in custodial institutions | Q71541469 | ||
| The response of man to virulent Shigella flexneri 2a | Q72377709 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipopolysaccharide | Q421804 |
| P304 | page(s) | 2341-2350 | |
| P577 | publication date | 1991-07-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides | |
| P478 | volume | 59 |
| Q39510614 | Adaptive immune response to Shigella flexneri 2a cydC in immunocompetent mice and mice lacking immunoglobulin A. |
| Q37120727 | Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates |
| Q34809879 | Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates. |
| Q52337397 | Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex. |
| Q30579709 | B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection |
| Q33608118 | Characterization of B-cell epitopes on IpaB, an invasion-associated antigen of Shigella flexneri: identification of an immunodominant domain recognized during natural infection |
| Q37067264 | Circulating Gut-Homing (α4β7+) Plasmablast Responses against Shigella Surface Protein Antigens among Hospitalized Patients with Diarrhea |
| Q36844719 | Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road |
| Q36101210 | Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries |
| Q35548702 | Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1. |
| Q40444589 | Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: preclinical evidence of immunogenicity and protection |
| Q59138059 | Cross-Protective Whole-Cell Vaccine With a Truncated O-Polysaccharide Chain |
| Q38853686 | Detergent Isolation Stabilizes and Activates the Shigella Type III Secretion System Translocator Protein IpaC. |
| Q37643320 | Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine. |
| Q35449575 | Development of an improved animal model of shigellosis in the adult rabbit by colonic infection with Shigella flexneri 2a |
| Q30425379 | Enteric pathogens through life stages |
| Q37032264 | Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD. |
| Q34068059 | Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans |
| Q31169709 | Identification and characterization of B-cell epitopes of IpaC, an invasion-associated protein of Shigella flexneri |
| Q33753646 | Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD) |
| Q37064863 | Immune response against lipopolysaccharide and invasion plasmid-coded antigens of shigellae in Vietnamese and Swedish dysenteric patients. |
| Q35521181 | Immune response to Shigella sonnei in U.S. Marines |
| Q39822100 | Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis |
| Q38648043 | In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity. |
| Q35480510 | Induction of a local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate: implications for use of IpaC as a protein carrier |
| Q36890938 | Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics |
| Q37720658 | Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes |
| Q33497678 | Lipopolysaccharide-specific antibodies in plasma and stools of children with Shigella-associated leukemoid reaction and hemolytic-uremic syndrome |
| Q36365336 | Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis |
| Q84938205 | Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice |
| Q43623067 | Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice |
| Q38605714 | Outer membrane proteins analysis of Shigella sonnei and evaluation of their antigenicity in Shigella infected individuals. |
| Q37105553 | Progress and pitfalls in Shigella vaccine research |
| Q28354066 | Role of T3SS-1 SipD Protein in Protecting Mice against Non-typhoidal Salmonella Typhimurium |
| Q59809065 | Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial |
| Q40501431 | Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial |
| Q37175693 | Secretory IgA: arresting microbial pathogens at epithelial borders |
| Q53347676 | Selective deletion of CD8(+) cells upregulated by caspases-1 via IL-18 in mice immunized with major outer membrane protein of Shigella dysenteriae 1 following infection. |
| Q35225017 | Serum antibody to lipopolysaccharide antigens of Shigella species among U.S. military personnel deployed to Saudi Arabia and Kuwait during Operations Desert Shield and Desert Storm. |
| Q36920244 | Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a. |
| Q43432983 | Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection. |
| Q41452318 | Shigellosis: from molecular pathogenesis of infection to protective immunity and vaccine development |
| Q73622781 | Titres of specific antibodies to poliovirus type 3 and tetanus toxoid in saliva and serum of children with recurrent upper respiratory tract infections |
Search more.